GlassScriptPhysician profile
Iryna Rika Singh
NPI 1831659408
$2,830.41
in general payments reported to CMS, 2019-2025
22 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,135 · 2022: $746 · 2023: $445 · 2024: $33.77 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $431.92 | 2021-2022 | |
| Seagen INC. | $365.66 | 2021-2023 | Tukysa |
| Puma Biotechnology, INC. | $283.67 | 2021-2023 | Nerlynx |
| Amgen INC. | $209.36 | 2021 | |
| Merck Sharp & Dohme LLC | $198.06 | 2022-2023 | Keytruda |
| Gilead Sciences, INC. | $181.69 | 2021-2025 | Trodelvy |
| Delcath Systems | $175.04 | 2025 | Hepzato Kit |
| Daiichi Sankyo INC. | $164.43 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.06 | 2021-2022 | |
| Pfizer INC. | $123.26 | 2021-2025 | |
| Janssen Biotech, INC. | $114.65 | 2022 | |
| Array Biopharma INC | $103.27 | 2024-2025 | Braftovi, Tukysa, Mektovi |
| Genentech USA, INC. | $78.11 | 2021 | |
| Novartis Pharmaceuticals Corporation | $61.39 | 2021 | |
| Heron Therapeutics, INC. | $41.62 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $36.03 | 2021 | |
| Ge Healthcare | $30.44 | 2022 | |
| Emd Serono, INC. | $23.44 | 2021 | |
| Novocure INC. | $21.59 | 2023 | Optune |
| Incyte Corporation | $21.43 | 2021 | |
| Mylan Institutional INC. | $20.28 | 2021 | |
| Foundation Medicine, INC. | $20.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iryna Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.